NexOptic Technology Corp. (NXO.V)
| Previous Close | 0.0400 |
| Open | 0.0450 |
| Bid | 0.0400 x 0 |
| Ask | 0.0450 x 0 |
| Day's Range | 0.0400 - 0.0450 |
| 52 Week Range | 0.0250 - 0.1250 |
| Volume | |
| Avg. Volume | 71,107 |
| Market Cap | 7.809M |
| Beta (5Y Monthly) | 1.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | Nov 29, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
NexOptic Begins Announcing New Team Additions
VANCOUVER, BC / ACCESSWIRE / December 4, 2023 / ("NexOptic") (TSX VENTURE:NXO)(OTCQB:NXOPF)(FSE:E3O1), a company developing cutting-edge AI and imaging technologies reports that, further to its November 20th news release, the Company is today announcing ...
- ACCESSWIRE
NexOptic Announces Forthcoming Team Additions
VANCOUVER, BC / ACCESSWIRE / November 20, 2023 / ("NexOptic") (TSX VENTURE:NXO)(OTCQB:NXOPF)(FSE:E3O1), a company developing cutting-edge AI and imaging technologies is excited to report that it has been assembling and is now in the process of onboarding ...
CNW GroupNexOptic Edges Closer to Commercialization
("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1), a company developing cutting-edge AI and imaging technologies, announces that it is nearing the point of first revenue. NexOptic Technology Corp and Pristine Surgical LLC are in an exclusive SaaS model partnership whereby NexOptic's artificial intelligence (AI) powered imaging technology is licensed for use into Pristine's single-use endoscopic visualization platform called Summit™. Summit is a single-use surgical arthroscope designed to make
